Viemed Healthcare, Inc. (VMD): Price and Financial Metrics

Viemed Healthcare, Inc. (VMD): $6.80

0.20 (-2.86%)

POWR Rating

Component Grades








Add VMD to Watchlist
Sign Up

Industry: Medical - Services




#6 of 69

in industry

VMD Price/Volume Stats

Current price $6.80 52-week high $12.01
Prev. close $7.00 52-week low $5.55
Day low $6.78 Volume 177,824
Day high $6.99 Avg. volume 145,643
50-day MA $8.05 Dividend yield N/A
200-day MA $8.92 Market Cap 260.32M

VMD Stock Price Chart Interactive Chart >


  • VMD scores best on the Sentiment dimension, with a Sentiment rank ahead of 93.28% of US stocks.
  • VMD's strongest trending metric is Growth; it's been moving up over the last 177 days.
  • VMD ranks lowest in Momentum; there it ranks in the 14th percentile.

VMD Stock Summary

  • With a price/earnings ratio of 37.41, VIEMED HEALTHCARE INC P/E ratio is greater than that of about 83.23% of stocks in our set with positive earnings.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at 1.29 for VIEMED HEALTHCARE INC; that's greater than it is for only 16.67% of US stocks.
  • With a year-over-year growth in debt of 206.66%, VIEMED HEALTHCARE INC's debt growth rate surpasses 94.59% of about US stocks.
  • If you're looking for stocks that are quantitatively similar to VIEMED HEALTHCARE INC, a group of peers worth examining would be NVEE, RAVE, EEFT, SBCF, and FC.
  • Visit VMD's SEC page to see the company's official filings. To visit the company's web site, go to

VMD Valuation Summary

  • In comparison to the median Healthcare stock, VMD's price/earnings ratio is 40.07% higher, now standing at 37.4.
  • Over the past 50 months, VMD's price/earnings ratio has gone up 11.4.

Below are key valuation metrics over time for VMD.

Stock Date P/S P/B P/E EV/EBIT
VMD 2023-09-22 1.8 2.6 37.4 27.6
VMD 2023-09-21 1.7 2.6 37.1 27.4
VMD 2023-09-20 1.8 2.6 37.4 27.6
VMD 2023-09-19 1.8 2.6 37.6 27.8
VMD 2023-09-18 1.8 2.7 38.7 28.5
VMD 2023-09-15 1.8 2.7 38.1 28.1

VMD's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • VMD has a Quality Grade of B, ranking ahead of 93.39% of graded US stocks.
  • VMD's asset turnover comes in at 1.029 -- ranking 20th of 81 Healthcare stocks.
  • 500 - Internal server error

The table below shows VMD's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 1.029 0.627 0.182
2021-06-30 1.069 0.614 0.202
2021-03-31 1.204 0.606 0.353
2020-12-31 1.234 0.610 0.396
2020-09-30 1.151 0.593 0.354
2020-06-30 1.150 0.628 0.338

VMD Price Target

For more insight on analysts targets of VMD, see our VMD price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $11.33 Average Broker Recommendation 1.5 (Moderate Buy)

Viemed Healthcare, Inc. (VMD) Company Bio

Viemed Healthcare, Inc. provides health care services. The Company offers respiratory disease management, neuromuscular care, home sleep testing, equipment solutions, sleep apnea treatment, and oxygen therapy services. Viemed Healthcare also offers rental of ventilator and peripheral equipment. Viemed Healthcare serves patients in the United States.

VMD Latest News Stream

Event/Time News Detail
Loading, please wait...

VMD Latest Social Stream

Loading social stream, please wait...

View Full VMD Social Stream

Latest VMD News From Around the Web

Below are the latest news stories about VIEMED HEALTHCARE INC that investors may wish to consider to help them evaluate VMD as an investment opportunity.

Viemed Healthcare to Participate in Upcoming Investor Conferences

LAFAYETTE, La., Aug. 31, 2023 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD and TSX:VMD.TO), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it will participate in the following upcoming investor conferences: Baird Global Healthcare Conference - 2023 Casey Hoyt, CEO, will participate in a panel presentation to discuss home medical equipment & supplies market trends and outlook. Management wil

Yahoo | August 31, 2023

The 7 Most Undervalued Stocks Under $10 to Buy Now: August 2023

While consumer prices may be hot, these stocks undervalued stocks to buy under $10 proves you can still catch a bargain.

Josh Enomoto on InvestorPlace | August 16, 2023

Viemed Healthcare (TSE:VMD) Might Be Having Difficulty Using Its Capital Effectively

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Ideally, a...

Yahoo | August 10, 2023

Viemed Healthcare Announces Second Quarter 2023 Financial Results

LAFAYETTE, La., Aug. 09, 2023 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD and TSX:VMD.TO), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it has reported its financial results for the three and six months ended June 30, 2023. Operational highlights (all dollar amounts are USD): Net revenues attributable to the Company's core business for the quarter ended June 30, 2023 reached a new Compan

Yahoo | August 9, 2023

Viemed Healthcare Announces Date and Time for Conference Call

LAFAYETTE, La., July 25, 2023 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD and TSX:VMD.TO), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it will host its Quarterly Conference Call on Thursday, August 10, 2023 at 11:00 a.m. ET. Interested parties may participate in the call by dialing: 877-407-6176 (US Toll-Free)+1 201-689-8451 (International) Financial professionals are invited to call in

Yahoo | July 25, 2023

Read More 'VMD' Stories Here

VMD Price Returns

1-mo -12.60%
3-mo -27.89%
6-mo -27.89%
1-year 20.78%
3-year -22.55%
5-year 31.78%
YTD -10.05%
2022 44.83%
2021 -32.73%
2020 25.16%
2019 63.16%
2018 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!